 CORAL GABLES, Fla., Sept. 09, 2022 GLOBE NEWSWIRE -- Catalyst Pharmaceuticals, Inc. Catalyst Nasdaq: CPRX, a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that Patrick J. McEnany, Chairman and CEO of Catalyst, along with other members of the management team, will participate in the hybrid in-person and virtual H.C. Wainwright 24th Annual Global Investment Conference being held on September 12-14, 2022. 